White Paper: Digital Drug Companions Create Millions for Pharma

Supporting patient engagement is not only a growing strategic initiative for pharma companies but is proving to be an impactful value driver.

In today’s competitive world of pharma brands, with a narrowing share of patients and contrasting engagement channels, advanced digital solutions offer new opportunities to create value and build loyalty that leads to greater persistence and improved outcomes.

This paper describes how today’s next-gen digital solutions can deliver meaningful results for patients, providers, and pharma organizations when they have five critical elements:

  1. Personalized engagement using AI
  2. Scalability
  3. Patient-centric messaging
  4. Adaptable and integrated platform
  5. Enhanced real-world evidence

Click here to see the white paper (no registration required):
Transforming How Pharma Delivers Value

You may also like

Medisafe Announces Launch of GOMEKLI™ Digital Companion to Support Patients with NF1-PN Taking GOMEKLI

BOSTON, MA / May 13, 2025 / Medisafe, the leading digital health platform for medication engagement, today announced a collaboration 

..Read More

Medisafe PATHWAYS, Eisai and Biogen Recognized for Alzheimer’s Disease Innovation in 2025 MedTech Breakthrough Awards Program

LOS ANGELES, Calif., – May 8, 2025 – MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, 

..Read More

Medisafe Launches VIA: AI Voice Tech That Supercharges Patient Engagement and Slashes Enrollment Friction

BOSTON, MA / ACCESS Newswire / April 22, 2025 / Medisafe today launched VIA (Voice Intelligent Agent) – a breakthrough 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.